Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 15 | 10 | 91 | 120 | 105 |
| Cost of Goods | N/A | N/A | N/A | N/A | -122 |
| Gross Profit | 15 | 10 | 91 | 120 | -92 |
| Operating Expenses | 29,938 | 46,467 | 130,486 | 32,221 | 2,725 |
| Operating Income | -29,923 | -46,457 | -130,395 | -32,101 | -2,620 |
| Interest Expense | 0 | 0 | 0 | 0 | 2 |
| Other Income | 2,799 | 145 | -498 | -747 | -125 |
| Pre-tax Income | -27,124 | -46,312 | -130,893 | -32,848 | -2,747 |
| Income Tax | -302 | N/A | N/A | 1 | 2 |
| Net Income Continuous | -26,822 | -46,312 | -130,893 | -32,849 | -2,749 |
| Net Income | $-26,822 | $-46,312 | $-130,893 | $-32,849 | $-2,749 |
| EPS Basic Total Ops | -0.19 | -0.59 | -1.99 | -0.54 | -0.05 |
| EPS Basic Continuous Ops | -0.19 | -0.60 | -1.99 | -0.54 | -0.05 |
| EPS Diluted Total Ops | -0.19 | -0.59 | -1.99 | -0.54 | -0.05 |
| EPS Diluted Continuous Ops | -0.19 | -0.60 | -1.99 | -0.54 | -0.05 |
| EBITDA(a) | $-29,394 | $-46,462 | $-129,435 | $-32,075 | $-2,200 |